Xcell Therapeutics, Inc. (373110.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.7x

Market Cap

KRW 15.58B

MomentumView details →

1D Return

−2.44%

YTD Return

−33.41%

RSI (14)

39.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.7x

Market Cap

KRW 15.58B

RSI (14)

39.3

MomentumView details →

1D Return

−2.44%

YTD Return

−33.41%

ProfitabilityView details →

Gross Margin

−48.21%

Net Margin

−253.53%

EBITDA Margin

−223.10%

ROE (TTM)

−255.64%

ROA (TTM)

−87.58%

Asset Turnover

0.32x

GrowthView details →

Revenue YoY

+193.70%

EPS YoY

+23.08%

FCF YoY

−9.31%

Revenue CAGR 3Y

+24.09%

EPS CAGR 3Y

−7.32%

EBITDA YoY

−53.46%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

1.24x

Current Ratio

1.28x

Quick Ratio

1.07x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

4.36B

Net Income (TTM)

−11.06B

Op. CF (TTM)

−10.25B

Latest newsMore news →

No recent news for 373110.KQ.

Similar companies

Jazz Pharmaceuticals plcJAZZ Metis Techbio-p07666.HK Exelixis, Inc.EXEL BridgeBio Pharma, Inc.BBIO 神州细胞688520.SH Summit Therapeutics Inc.SMMT Find similar companies →

Latest newsMore news →

No recent news for 373110.KQ.